NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept
In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial
DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects
Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume
House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI
NCI Audit Finds “Low Quality” Research At Calif. Foundation
DCE Board Approves Study of Breast Cancer On Long Island
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer









